- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
7
Companies which are more than 50% undervalued based on analyst price target.
7 companies
Caliway Biopharmaceuticals
Market Cap: NT$156.4b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$100.50
7D
-11.5%
1Y
-25.3%
Bora Pharmaceuticals
Market Cap: NT$51.1b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$401.00
7D
-3.5%
1Y
-41.8%
Lotus Pharmaceutical
Market Cap: NT$49.5b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$188.50
7D
-4.8%
1Y
-16.2%
Oneness Biotech
Market Cap: NT$23.0b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$47.90
7D
-4.8%
1Y
-27.2%
TaiMed Biologics
Market Cap: NT$16.1b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$59.00
7D
-10.6%
1Y
-29.3%
Medigen Vaccine Biologics
Market Cap: NT$15.4b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$46.80
7D
-1.9%
1Y
11.7%
Foresee Pharmaceuticals
Market Cap: NT$13.1b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$83.00
7D
1.7%
1Y
14.0%